Citation: Rp. Hart et al., VIGILANCE PERFORMANCE IN PARKINSONS-DISEASE AND DEPRESSION, Neuropsychology, development, and cognition. Section A, Journal of clinical and experimental neuropsychology, 20(1), 1998, pp. 111-117
Authors:
CALABRESE VP
LLOYD KA
BRANCAZIO P
CEFALI E
MARTIN P
WALL J
SICA D
Citation: Vp. Calabrese et al., N-0923, A NOVEL SOLUBLE DOPAMINE D-2 AGONIST IN THE TREATMENT OF PARKINSONISM, Movement disorders, 13(5), 1998, pp. 768-774
Authors:
TREIMAN DM
MEYERS PD
WALTON NY
COLLINS JF
COLLING C
ROWAN AJ
HANDFORTH A
FAUGHT E
CALABRESE VP
UTHMAN BM
RAMSAY RE
MAMDANI MB
Citation: Dm. Treiman et al., A COMPARISON OF 4 TREATMENTS FOR GENERALIZED CONVULSIVE STATUS EPILEPTICUS, The New England journal of medicine, 339(12), 1998, pp. 792-798
Citation: Ja. Rawes et al., ANTIBODIES TO THE AXOLEMMA-ENRICHED FRACTION IN THE CEREBROSPINAL-FLUID AND SERUM OF PATIENTS WITH MULTIPLE-SCLEROSIS AND OTHER NEUROLOGICAL DISEASES, Multiple sclerosis, 3(6), 1997, pp. 363-369
Authors:
CALABRESE VP
VAUGHAN J
LUCAS J
HONG AQ
BARRETT R
MARTIN P
SICA D
Citation: Vp. Calabrese et al., N-0923, A TRANSDERMAL AMINO TETRALIN D2 DOPAMINE AGONIST IN THE TREATMENT OF PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 32005-32005
Citation: Oa. Khan et al., PRESENCE OF ANTIBODIES TO THE AXOLEMMA IN THE CEREBROSPINAL-FLUID OF MULTIPLE-SCLEROSIS PATIENTS PRESENTING WITH ACUTE EXACERBATIONS, Neurology, 45(4), 1995, pp. 165-165
Authors:
PANDURANGI AK
PELONERO AL
NADEL L
CALABRESE VP
Citation: Ak. Pandurangi et al., BRAIN STRUCTURE CHANGES IN SCHIZOPHRENICS WITH HIGH SERUM TITERS OF ANTIBODIES TO HERPES-VIRUS, Schizophrenia research, 11(3), 1994, pp. 245-250
Authors:
KNAPP MJ
KNOPMAN DS
SOLOMON PR
PENDLEBURY WW
DAVIS CS
GRACON SI
APTER JT
LAZARUS CN
BAKER KE
BARNETT M
BAUMEL B
EISNER LS
CASTELLS B
BOLOURI R
BENNETT D
FORCHETTI C
LEVIN A
BLASS JP
NOLAN KA
GAINES ER
RELKIN N
BORISON RL
DIAMOND B
CELESIA GG
ROSS AP
DEXTER J
DOODY R
LIPSCOMB L
KREITER K
DUBOFF EA
BLOCK P
MARSHALL D
WESTERGAARD N
EARL NL
WYNE SV
HINMANSMITH E
FARLOW M
HENDRIE HC
CARESS JA
FARMER M
HARPER JE
FERGUSON J
FOSTER NL
BARBAS NR
BLUEMLEIN LA
GELB DJ
BERENT S
GIORDANI B
GREENWALD M
BERGMAN S
ROGER LF
GROENENDYK A
WOOD M
JURKOWSKI C
KATZ I
DOYLE S
SMITH BD
KELLNER C
BERNSTEIN HJ
BACHMAN DL
KNOPMAN DS
DEINARD S
LANGLEY L
BRIDGES S
MARGOLIN RA
BURGER MC
WISER SL
CRENSHAW C
MORRIS JC
RUBIN EH
COATS MA
REYES PF
BENTZ C
DOYLE LL
RYMER MM
BETTINGER IE
LAUBINGER MP
SADOWSKY CH
MARTINEZ W
ZUNIGA J
STONE R
WINNER P
MATE L
LESSARD C
SCHNEIDER L
PAWLUCZYK S
SMITH WT
LOSK SN
MARAMBE L
SOLOMON PR
PENDLEBURY WW
GROCCIAELLISON ME
EDWARDS KR
TAYLOR J
CALABRESE VP
HARKINS SW
THEIN SG
DEWAR JA
WILLIAMS G
DRENNAN C
TUTTLE P
PRINCIPI N
FORD EM
TYNDALL RJ
KELLEY CK
Citation: Mj. Knapp et al., A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE, JAMA, the journal of the American Medical Association, 271(13), 1994, pp. 985-991
Authors:
CALABRESE VP
GRUEMER HD
TRIPATHI HL
DEWEY W
FORTNER CA
DELORENZO RJ
Citation: Vp. Calabrese et al., SERUM CORTISOL AND CEREBROSPINAL-FLUID BETA-ENDORPHINS IN STATUS EPILEPTICUS - THEIR POSSIBLE RELATION TO PROGNOSIS, Archives of neurology, 50(7), 1993, pp. 689-693